STOCKHOLM, SE / ACCESSWIRE / October 10, 2024 / (STO:ALZCUR) (FRA:AC6) AB (publ) (FN STO: ALZCUR), a pharmaceutical company ...

Lyka Labs shares rose as the company announced that it has received the CDSCO approval for manufacturing & marketing of of ...

ACD440 is a first-in-class TRPV1 antagonist in clinical phase being developed as a new topical local treatment for peripheral neuropathic pain. The drug candidate, which was incorporated via ...

Scientists from UNSW Sydney have developed interactive software which could be used to help people who are experiencing ...

topical creams, and gels have gained popularity. These medications are applied directly to the affected area, offering pain relief without the side effects associated with oral medications.

Although systematic reviews have outlined the current treatment options for neuropathic pain, subsequent trials have necessitated an update of the NUMBER NEEDED TO TREAT (NNT) values presented in ...

All painkillers have potential side effects, and this is why many are ditching over-the-counter meds for pain in favor of CBD balms, creams, and balms. Whether you are dealing with sore muscles due ...

Millions of Americans suffer from chronic back pain, but for Gene Forrest, the pain became insufferable.  “The pain can be so ...

Although pregabalin is mechanistically similar to gabapentin and shares similar advantages, such as a lack of pharmacokinetic interactions with other medications or enzyme induction, there are ...

Furthermore, Dr. Sherif’s presentation will highlight upcoming near-term milestones, including the topline results from the ACUITY Phase 2 trial with OCS-05 for the treatment of acute optic neuritis, ...

How does our brain register an itch? We find out from a National Skin Centre expert why medical conditions such as chronic ...